Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Insmed Incorporated
Related studies linked through entity extraction aliases.
Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
- Status
- COMPLETED
- Phase
- PHASE2
Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2